Add BrightSurf on Google Email

Deadly diets driving digestive diseases

Researchers urge people to improve their eating habits to reduce the risk of bowel cancer, citing evidence that high-fibre foods promote healthy gut bacteria. Studies found a link between poor diet choices and digestive cancers, highlighting the importance of diets rich in whole grains, vegetables, fruits, and legumes.

SourceFlinders University·JournalEuropean Journal of Nutrition·TypeData/statistical analysis·DateDec 1, 2024

Curbing plastics pollution could help reduce global burden of breast cancer

A new study suggests that addressing plastic pollution could play a critical role in lowering breast cancer rates. Researchers identified nearly half of the chemicals linked to breast cancer risk as being used in plastics, including 175 potential carcinogens that should be prioritized for regulatory action.

SourceSilent Spring Institute·JournalEnvironmental Science & Technology Letters·TypeData/statistical analysis·DateNov 29, 2024

Home testing kits and coordinated outreach substantially improve colorectal cancer screening rates

A new study shows that mailing at-home fecal immunochemical testing kits and providing coordinated follow-up led to a tripling of screening completion rates compared to usual care. The intervention increased screening rates by 30% within six months and 34.6% by 12 months.

SourceUniversity of North Carolina Health Care·JournalJAMA Network Open·TypeRandomized controlled/clinical trial·DateNov 25, 2024

Cancer genetic risk assessment guidelines expand to meet growing understanding of hereditary risk

The National Comprehensive Cancer Network has updated its guidelines for genetic/familial high-risk assessment, incorporating the latest scientific research and expert recommendations to enhance screening practices and treatment options. The expanded guidelines cover various cancer types and provide guidance on genetic testing, heredit...

Discovery of cancer risk associations for six novel genes

Researchers identified six novel genes associated with a significant increase in cancer risk, including BIK for prostate cancer, ATG12 for colorectal cancer, and CMTR2 for lung and melanoma. Loss of AURKB was found to protect against any cancer type, while loss of PPP1R15A was linked to a 53% lower risk of breast cancer.

SourcedeCODE genetics·JournalNature Genetics·TypeMeta-analysis·DateOct 29, 2024

Moffitt study reveals insights into oral HPV incidence and risks in men across 3 countries

A new study by H. Lee Moffitt Cancer Center researchers has uncovered crucial information about the incidence and risk factors of oral human papillomavirus (HPV) infections among men in the US, Mexico, and Brazil. The study found that the risk of acquiring oral HPV was notably higher in the US compared to Brazil and Mexico.

SourceH. Lee Moffitt Cancer Center & Research Institute·JournalNature·TypeData/statistical analysis·DateOct 21, 2024

Study suggests a healthy diet may help keep low grade prostate cancer from progressing to more dangerous states during active surveillance

A new study suggests that a healthy diet may help keep low-grade prostate cancer from progressing to more aggressive states in men undergoing active surveillance. The research team led by Johns Hopkins Medicine found that a reduced risk of prostate cancer progression is associated with a healthy diet.

SourceJohns Hopkins Medicine·JournalJAMA Oncology·DateOct 17, 2024

AI algorithm for subclinical breast cancer detection

A retrospective cohort study found that AI algorithms can identify women at high risk of developing breast cancer 4-6 years before detection. The results suggest using commercial AI algorithms as a pathway to personalized screening approaches, leading to earlier cancer diagnosis.

SourceJAMA Network·JournalJAMA Network Open·DateOct 3, 2024

Researchers receive grant to boost colorectal cancer screening follow-up in underserved communities

A new study aims to increase follow-up care for patients who receive abnormal stool-based fecal immunochemical tests, focusing on improving coordination between primary and specialty clinics. The goal is to improve colorectal cancer screening processes in underserved populations, increasing survival and reducing mortality.

More clarity on hereditary colorectal cancer

A large proportion of gene variants previously classified as 'variants of uncertain significance' (VUS) have been reclassified as benign, according to a study published in the American Journal of Human Genetics. This reduces the total number of VUS by 37%, providing relief for carriers worldwide.

SourceUniversitatsklinikum Bonn·JournalAmerican Journal of Human Genetics·DateOct 1, 2024

New prostate biopsy technique lowers infection risk

A new prostate biopsy technique, transperineal biopsy, has been shown to lower the risk of infection compared to traditional biopsies. The PREVENT trial found no infections among men who underwent the transperineal procedure, while those with traditional transrectal biopsies had a 1.6% infection rate despite receiving antibiotics.

SourceWeill Cornell Medicine·JournalJAMA Oncology·DateSep 19, 2024

Incidence of neuroleptic malignant syndrome during antipsychotic treatment in children and youth

A new study found that patients with 4 or 5 identified risk factors, including age 18-24 years and schizophrenia spectrum disorders, had over 100 times the incidence of Neuroleptic Malignant Syndrome. The data provide a basis for early identification and monitoring of children and youth at elevated risk.

SourceMary Ann Liebert, Inc./Genetic Engineering News·JournalJournal of Child and Adolescent Psychopharmacology·TypeData/statistical analysis·DateSep 18, 2024

Black women have a higher risk of dying from all types of breast cancer, meta-analysis reveals

A meta-analysis by Mass General Brigham researchers found that Black women face higher mortality rates from breast cancer across all tumor subtypes, attributed to socioeconomic inequality, delayed diagnosis, and inadequate access to timely quality treatment. This disparity is not limited to hormone-positive tumors, with differences als...

SourceMass General Brigham·JournalJournal of Clinical Oncology·TypeMeta-analysis·DateSep 17, 2024

The RESILIENCE trial: Preventing heart injury caused by anticancer drugs

The RESILIENCE clinical trial explores the effectiveness of remote ischemic conditioning to prevent cardiotoxicity in lymphoma patients undergoing anthracycline-based chemotherapy. The trial aims to reduce heart failure prevalence and improve quality of life for cancer survivors.

SourceCentro Nacional de Investigaciones Cardiovasculares Carlos III (F.S.P.)·JournalEuropean Journal of Heart Failure·TypeRandomized controlled/clinical trial·DateSep 13, 2024

BMI’s relation to cancer therapy mortality risks not so straightforward

A study published in JAMA Network Open found that body mass index (BMI) has a more complex relationship with mortality risk during cancer therapy than previously thought. For patients with advanced non-small cell lung cancer, higher BMI was associated with lower mortality when undergoing immunotherapy or conventional chemotherapy. Howe...

SourceOsaka Metropolitan University·JournalJAMA Network Open·TypeObservational study·DateSep 12, 2024

Breaking the trend: Skin cancer incidence in young adults declines

A new study found that skin cancer incidence in young adults declined in Sweden around 2015. The decrease in incidence and mortality is attributed to increased awareness of sun protection, reduced access to sunbeds, and changes in lifestyle habits such as spending more time indoors. The study suggests that continued emphasis on sun pro...

SourceKarolinska Institutet·JournalJAMA Dermatology·TypeObservational study·DateSep 8, 2024